KZIA SCHEDULE 13G/A: SEC filing
An institutional investor
Filed with the SEC on · accession 0001193125-26-352951
KZIA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +2.3% by the first close after the filing.
Summary of the filing
An institutional investor filed an amended Schedule 13G disclosing its passive ownership stake in Kazia Therapeutics Ltd. The filing indicates a change in the holder's previously reported position.
Key details
How KZIA stock reacted
Close before
$13.21
Aug 13, 2026
First close after
+2.35%
$13.52
5 trading days
+3.41%
$13.66
Since filing
-45.65%
$7.18
✦ Ask GOAX AI about this filing — what it means for KZIA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for KZIA?
Click hereFrequently asked questions
What did KZIA file with the SEC on Aug 14, 2026?
KZIA filed a SCHEDULE 13G/A (SEC filing). An institutional investor filed an amended Schedule 13G disclosing its passive ownership stake in Kazia Therapeutics Ltd. The filing indicates a change in the holder's previously reported position.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did KZIA stock react to this filing?
KZIA closed at $13.21 before the filing and $13.52 on Aug 14, 2026 (+2.35%). Five trading days later: $13.66 (+3.41%).
Other KZIA SEC filings
- SCHEDULE 13G/A · SEC filingOct 2, 2026
- 424B3 · SEC filingSep 22, 2026
- 424B3 · SEC filingSep 22, 2026
- 424B3 · SEC filingSep 22, 2026
- 6-K · Fda approvalSep 22, 2026
- 424B3 · SEC filingSep 22, 2026
- 424B3 · SEC filingSep 18, 2026
- 6-K · SEC filingSep 18, 2026
- 6-K · Fda approvalSep 1, 2026
- 424B5 · Secondary offeringAug 31, 2026
Get alerts when KZIA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days